Abstract
Pharmacogenomics (PGx) knowledge and practical applications in academic medicine and public health are expanding worldwide. In the past ten years, genotyping technologies have emerged in Jordan through the establishment of several research centers and university departments. The goals of this study were to assess the extensiveness, depth, and perceived importance of PGx instruction, in addition to the knowledge and use of PGxin academic medicine and public health in Jordan.A previously published questionnaire was modified and further developed and sent to medical academicians and public health workers. A total of 200 individuals in academic medicine and public health were invited to participate in the survey. The response rate was 75%. Approximately41% of respondents studied PGx at school. Coverage of PGxin departments of genetics and faculties of pharmacy was33% for <10 hours, 8% for 10-30 hours,2% for 31-60 hours and 6% for>60 hours. In terms of medical practice, the most frequently applied PGx topics were drug side effects (43%) and drug selection (35%). Nearly21% of PGx users reported they had been asked questions that require PGx knowledge by physicians whereas29% reported such questions from patients. Respondents considered their own PGx training inadequate, with a mean (±SD) value of 2.0± 1.0 (1 = very inadequate, 5 = very adequate). More PGx training is needed in order to establish good PGx education and apply PGx services in developing countries including Jordan. If PGx applications expand in academic medicine and public health as anticipated, the need to develop training capabilities will be even larger.
Keywords: Drug, education, jordan, medicine, pharmacogenomics, public health, questionnaire.
Current Pharmacogenomics and Personalized Medicine
Title:Emergence of Pharmacogenomics in Academic Medicine and Public Health in Jordan: History, Present State and Prospects
Volume: 12
Author(s): Laith N. Al-Eitan and Yazan A. Haddad
Affiliation:
Keywords: Drug, education, jordan, medicine, pharmacogenomics, public health, questionnaire.
Abstract: Pharmacogenomics (PGx) knowledge and practical applications in academic medicine and public health are expanding worldwide. In the past ten years, genotyping technologies have emerged in Jordan through the establishment of several research centers and university departments. The goals of this study were to assess the extensiveness, depth, and perceived importance of PGx instruction, in addition to the knowledge and use of PGxin academic medicine and public health in Jordan.A previously published questionnaire was modified and further developed and sent to medical academicians and public health workers. A total of 200 individuals in academic medicine and public health were invited to participate in the survey. The response rate was 75%. Approximately41% of respondents studied PGx at school. Coverage of PGxin departments of genetics and faculties of pharmacy was33% for <10 hours, 8% for 10-30 hours,2% for 31-60 hours and 6% for>60 hours. In terms of medical practice, the most frequently applied PGx topics were drug side effects (43%) and drug selection (35%). Nearly21% of PGx users reported they had been asked questions that require PGx knowledge by physicians whereas29% reported such questions from patients. Respondents considered their own PGx training inadequate, with a mean (±SD) value of 2.0± 1.0 (1 = very inadequate, 5 = very adequate). More PGx training is needed in order to establish good PGx education and apply PGx services in developing countries including Jordan. If PGx applications expand in academic medicine and public health as anticipated, the need to develop training capabilities will be even larger.
Export Options
About this article
Cite this article as:
Al-Eitan N. Laith and Haddad A. Yazan, Emergence of Pharmacogenomics in Academic Medicine and Public Health in Jordan: History, Present State and Prospects, Current Pharmacogenomics and Personalized Medicine 2014; 12 (3) . https://dx.doi.org/10.2174/1875692113666150115221210
DOI https://dx.doi.org/10.2174/1875692113666150115221210 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
Letters in Drug Design & Discovery Chronic Stress Impacts on Olfactory System
CNS & Neurological Disorders - Drug Targets Novel Quercetin Glycosides as Potent Anti-MRSA and Anti-VRE Agents
Recent Patents on Anti-Infective Drug Discovery Chemistry and Applications of 4-Hydroxyquinolin-2-one and Quinoline-2,4-dionebased Compounds
Current Organic Chemistry Herbal Medicine for Anxiety, Depression and Insomnia
Current Neuropharmacology Enhanced α-Synuclein Expression in Human Neurodegenerative Diseases: Pathogenetic and Therapeutic Implications
Current Protein & Peptide Science Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-κB
Current Drug Targets - Inflammation & Allergy Precipitation Processes with Supercritical Fluids: Patents Review
Recent Patents on Engineering On Illicit Drug Policies; Methods of Evaluation and Comments on Recent Practices
Current Drug Abuse Reviews Editorial: Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives
Current Alzheimer Research Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets Mitochondrial Effects of Organoselenium and Organotellurium Compounds
Current Organic Chemistry Chemical and Pharmacological Aspects of Heteroaryl-Nitrones
Current Medicinal Chemistry Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets How to Inhibit Telomerase Activity for Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Variability in the Response to Non-pharmacological Treatments in Patients with Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine Role of Dietary Polyphenols in Attenuating Brain Edema and Cell Swelling in Cerebral Ischemia
Recent Patents on CNS Drug Discovery (Discontinued) Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Antiviral Medication in Sexually Transmitted Diseases. Part III: Hepatitis B, Hepatitis C
Mini-Reviews in Medicinal Chemistry Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy
Current Drug Targets - Inflammation & Allergy